Search Results - caleb+anderson

2 Results Sort By:
Peptide for the Prevention and Treatment of Coronavirus Infection
Value Proposition·        Peptide-based supramolecular filament that attenuates SARS-CoV virus infectivity in vivo·        Leverages ACE2 enzyme-substrate docking activity·        Enables therapeutic protein delivery in repairable aerosolsUnmet Need·        Respiratory illnesses, including tuberculosis, influenza, and COVID-19, pose a significant worldwide...
Published: 3/14/2025   |   Inventor(s): Honggang Cui, Hongpeng Jia, Caleb Anderson
Keywords(s):  
Category(s): Clinical and Disease Specializations > Respiratory Diseases, Technology Classifications > Therapeutic Modalities > Peptides, Technology Classifications > Therapeutic Modalities > Vaccines, Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms
Inhalable Supramolecular Therapeutics to Treat Lung Diseases
Unmet NeedThe current global market for respiratory drugs is expected to increase from $30.9 billion in 2016 to $41.3 billion in 2023. While many aerosol therapeutics are used to treat lung diseases such as chronic obstructive pulmonary disease, asthma, and cystic fibrosis, administration of drugs selectively to the lungs remains challenging. The nature...
Published: 3/14/2025   |   Inventor(s): Honggang Cui, Caleb Anderson
Keywords(s): Disease Indication, Drug Delivery Mechanism, Drug Delivery Vehicle, Drug Delivery Vehicle Synthesis Method, Lung Disorders, Polymers, Therapeutic Matter, Therapeutics
Category(s): Clinical and Disease Specializations > Respiratory Diseases, Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms, Technology Classifications > Therapeutic Modalities > Dendrimers & Polymers
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum